Septerna, Inc. (NASDAQ:SEPN) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Septerna, Inc. (NASDAQ:SEPN) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $52.4444.

SEPN has been the topic of several research reports. Wells Fargo & Company upped their price objective on shares of Septerna from $48.00 to $50.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. JonesTrading boosted their price target on shares of Septerna from $43.00 to $62.00 and gave the company a “buy” rating in a report on Thursday, August 13th. Truist Financial upped their price target on shares of Septerna from $35.00 to $43.00 and gave the stock a “buy” rating in a research note on Wednesday, July 1st. JPMorgan Chase & Co. increased their price objective on Septerna from $38.00 to $48.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Septerna in a research note on Friday, July 17th.

Insiders Place Their Bets

In other Septerna news, COO Elizabeth Bhatt sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $44.00, for a total value of $1,100,000.00. Following the completion of the sale, the chief operating officer directly owned 174,209 shares of the company’s stock, valued at $7,665,196. The trade was a 12.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Daniel Long sold 3,333 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $37.83, for a total transaction of $126,087.39. Following the transaction, the senior vice president owned 96,412 shares in the company, valued at approximately $3,647,265.96. This trade represents a 3.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 37,178 shares of company stock valued at $1,532,154 over the last ninety days. Corporate insiders own 5.80% of the company’s stock.

Institutional Investors Weigh In On Septerna

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. First Light Asset Management LLC boosted its position in Septerna by 31.4% during the second quarter. First Light Asset Management LLC now owns 963,260 shares of the company’s stock worth $32,260,000 after purchasing an additional 230,400 shares during the period. Engineers Gate Manager LP lifted its stake in shares of Septerna by 5.0% in the second quarter. Engineers Gate Manager LP now owns 17,350 shares of the company’s stock worth $581,000 after buying an additional 822 shares during the last quarter. Squarepoint Ops LLC grew its stake in Septerna by 17.3% in the 2nd quarter. Squarepoint Ops LLC now owns 21,219 shares of the company’s stock valued at $711,000 after buying an additional 3,136 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Septerna in the 2nd quarter valued at $445,000. Finally, Bank of America Corp DE acquired a new stake in shares of Septerna in the second quarter valued at about $1,201,000.

Septerna Trading Up 4.8%

Shares of NASDAQ SEPN opened at $40.38 on Wednesday. Septerna has a one year low of $15.86 and a one year high of $51.10. The firm has a market capitalization of $1.88 billion, a PE ratio of -74.78 and a beta of 2.30. The business has a 50-day moving average price of $38.31 and a two-hundred day moving average price of $32.03.

Septerna (NASDAQ:SEPN) last posted its quarterly earnings results on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.14. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.57%. The business had revenue of $26.75 million during the quarter, compared to analyst estimates of $19.22 million. Research analysts anticipate that Septerna will post -1.41 EPS for the current year.

Septerna Company Profile

Septerna, Inc is a clinical-stage biotechnology company focused on discovering and developing oral small-molecule medicines that target G protein-coupled receptors (GPCRs). GPCRs are a large class of cell-surface proteins involved in numerous biological processes and are established targets for therapies across a range of diseases.

The company uses its proprietary Native Orthosteric Ligand Discovery platform to study GPCRs in their native cellular environments and identify small-molecule compounds that can modulate these receptors.